| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/15/2011 | WO2011110852A1 Polymorphic forms of 6- [2- (4 -cyanophenyl) - 2h - pyrazol - 3 - yl] - 5 -methyl - 3 - oxo - 4 - (trifluoromethyl - phenyl) 3,4-dihydropyrazine-2-carboxylic acid ethylamide |
| 09/15/2011 | WO2011110842A2 Inhibitors of glucose metabolism for use in the treatment of birt-hogg-dube syndrome |
| 09/15/2011 | WO2011110824A1 Bis aromatic compounds for use as ltc4 synthase inhibitors |
| 09/15/2011 | WO2011110723A1 N-acetylhexosamine sulfur derivatives and use of same as cell tumor inhibitors |
| 09/15/2011 | WO2011110683A2 Glce as a target for anti-tumour therapy |
| 09/15/2011 | WO2011110671A2 Pharmaceutical composition for the treatment of chlamydial infection |
| 09/15/2011 | WO2011110661A1 Antioxidant composition for reducing oxidative stress ascribable to the treatment with hormonal contraceptive drugs |
| 09/15/2011 | WO2011110613A1 Heterocyclic inhibitors of glutaminyl cyclase (qc, ec 2.3.2.5) |
| 09/15/2011 | WO2011110612A1 Inhibitors of protein kinases |
| 09/15/2011 | WO2011110608A1 Treatment of dementia of alzheimer's type with masitinib |
| 09/15/2011 | WO2011110595A1 Crystalline salts and/or cocrystals of o-desmethyltramadol |
| 09/15/2011 | WO2011110575A1 Derivatives of 2-[2-(benzo- or pyrido-) thiazolylamino]-6-aminopyridine, useful in the treatment of respiratoric, allergic or inflammatory diseases |
| 09/15/2011 | WO2011110546A2 Pharmaceutical composition comprising an inhibitor of shp-2 and screening method |
| 09/15/2011 | WO2011110545A1 Imidazo [1, 2 -a] pyrazine derivatives and their use for the prevention or treatment of neurological, psychiatric and metabolic disorders and diseases |
| 09/15/2011 | WO2011110511A1 Spect imaging agents of amyloid plaques |
| 09/15/2011 | WO2011110488A1 A novel pet imaging agent of amyloid plaques and its precursor |
| 09/15/2011 | WO2011110478A1 Dabigatran etexilate-containing pharmaceutical composition |
| 09/15/2011 | WO2011110344A1 Multi-particulate pharmaceutical formulation for colon absorption |
| 09/15/2011 | WO2011110315A1 Carbon monoxide releasing rhenium compounds for medical use |
| 09/15/2011 | WO2011110225A1 Adhesive patch for therapeutic agent delivery |
| 09/15/2011 | WO2011110190A1 A cellobiose compound from herbal extracts having apoptotic activity |
| 09/15/2011 | WO2011110183A1 Azaisoquinolinone derivatives as nk3 antagonists |
| 09/15/2011 | WO2011110166A2 Solid pharmaceutical composition, comprising donepezil hydrochloride of the crystalline polymorphous form i |
| 09/15/2011 | WO2011110087A1 Combined use of ribonuclease and artemisinsin |
| 09/15/2011 | WO2011110084A1 Method for preparing isovalerylspiramycin i, ii or iii and pharmaceutical composition containing compound thereof |
| 09/15/2011 | WO2011109900A1 Food comprising glucomannan, xanthan gum and alginate for the treatment of metabolic disorders |
| 09/15/2011 | WO2011109899A1 Use of tigecycline for treatment of cancer |
| 09/15/2011 | WO2011109877A1 Heparan sulfate replacement therapy |
| 09/15/2011 | WO2011109874A1 Inhibition of glutathione transferase zeta |
| 09/15/2011 | WO2011091436A9 Quantitative analysis of vitamin d3, vitamin d2, and metabolites thereof |
| 09/15/2011 | WO2011088524A8 Methods for regulating blood glucose levels |
| 09/15/2011 | WO2011083287A3 Darunavir polymorph and process for preparation thereof |
| 09/15/2011 | WO2011082196A3 Rapid reconstitution for lyophilized-pharmaceutical suspensions |
| 09/15/2011 | WO2011071920A9 Promoting cycling of apoe4 isoform |
| 09/15/2011 | WO2011069921A9 Sucrose octasulfates of zinc, the preparation of same and the pharmaceutical and cosmetic uses thereof |
| 09/15/2011 | WO2011068403A3 Novel n-{3-ethynylphenylamino)-6,7-bis(2-methoxyethoxy)-4-quinazolinamjne salts |
| 09/15/2011 | WO2011065658A3 Method for extracting glyceollins for use in functional whitening preparations |
| 09/15/2011 | WO2011063150A3 Oral formulation for dexlansoprazole |
| 09/15/2011 | WO2011063048A3 Urinary triaosylceramide (gb3) as a marker of cardiac disease |
| 09/15/2011 | WO2011061032A3 Cells, nucleic acids, enzymes, and use thereof, and methods for the production of sophorolipids |
| 09/15/2011 | WO2011060427A9 Composition and methods for affecting cytokines and nf-kb |
| 09/15/2011 | WO2011060363A3 Cyclohexyl urea modulators of d2 receptors and/or d3 receptors |
| 09/15/2011 | WO2011060332A3 Compositions and methods for treating hyperproliferative disorders |
| 09/15/2011 | WO2011056788A3 Inhibiting neurotransmitter reuptake |
| 09/15/2011 | WO2011053764A3 Methods for the biosynthesis of taurine or hypotaurine in cells |
| 09/15/2011 | WO2011046411A3 Chestnut extracts with neuro cellular protective activity and acetylcholinesterase inhibiting activity, and use thereof |
| 09/15/2011 | WO2011041989A3 Tricyclic and tetracyclic systems with activity on the central-nervous and vascular systems |
| 09/15/2011 | WO2011038380A3 Combination |
| 09/15/2011 | WO2011037550A3 Dry powder combination of tiotropium |
| 09/15/2011 | WO2011031554A3 Heterocyclic compounds as janus kinase inhibitors |
| 09/15/2011 | WO2011021000A3 A process for the synthesis of naratriptan |
| 09/15/2011 | WO2011017165A8 Method of preventing renal disease and treating symptoms thereof |
| 09/15/2011 | WO2011013999A9 Composition containing chitooligosaccharide for recovering from fatigue |
| 09/15/2011 | WO2011009714A3 Benzoquinolizinium salt derivatives as anticancer agents |
| 09/15/2011 | WO2011006157A9 Rxr agonist compounds and methods |
| 09/15/2011 | WO2010147836A9 Combination therapies using antibacterial aminoglycoside compounds |
| 09/15/2011 | WO2010146407A9 Nanostructured sildenafil base, its pharmaceutically acceptable salts and co-crystals, compositions of them, process for the preparation thereof and pharmaceutical compositions containing them |
| 09/15/2011 | WO2010137032A3 Novel polymorphic forms of elvitegravir and its pharmaceutically acceptable salts |
| 09/15/2011 | WO2010135396A3 Formulations of 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione |
| 09/15/2011 | WO2010132839A9 Aminoglycoside dosing regimens |
| 09/15/2011 | WO2010132768A9 Antibacterial derivatives of sisomicin |
| 09/15/2011 | WO2010120662A3 Bioavailable compositions of amorphous alpha-(n-sulfonamido)acetamide compound |
| 09/15/2011 | WO2010089303A9 CYCLIC INHIBITORS OF 11 β-HYDROXYSTEROID DEHYDROGENASE 1 |
| 09/15/2011 | WO2010033188A3 Dosages for menstrual suppression, contraception, and hormone replacement therapy, and methods of administering same |
| 09/15/2011 | WO2005124563A9 Compounds and kits for treating muscle disorders and methods of use thereof |
| 09/15/2011 | US20110225676 Two Novel Alkylresorcinol Synthase Genes from Sorghum; Cloning, Expression, Transformation and Characterization |
| 09/15/2011 | US20110224724 Hydrogel tissue adhesive formed from aminated polysaccharide and aldehyde-functionalized multi-arm polyether |
| 09/15/2011 | US20110224723 Cyanoacrylate tissue adhesives |
| 09/15/2011 | US20110224599 Combination of an oxidant and a photoactivator for the healing of wounds |
| 09/15/2011 | US20110224596 Tissue Penetrating Catheters Having Integral Imaging Transducers and Their Methods of Use |
| 09/15/2011 | US20110224447 Novel Lipid Nanoparticles and Novel Components for Delivery of Nucleic Acids |
| 09/15/2011 | US20110224434 Prodrugs of Heteroaryl Compounds |
| 09/15/2011 | US20110224306 Use of canthaxanthin and/or 25-oh d3 for improved hatchability in poultry |
| 09/15/2011 | US20110224305 Phenylcyclobutylamide derivatives and their stereoisomers, the preparation processes and uses thereof |
| 09/15/2011 | US20110224304 Biphenylacetamide derivative |
| 09/15/2011 | US20110224303 Use of ci-994 and dinaline for the treatment of memory/cognition and anxiety disorders |
| 09/15/2011 | US20110224302 Difluorophenyldiacylhydrazide derivatives |
| 09/15/2011 | US20110224301 Hmgb1 expression and protective role of semapimod in nec |
| 09/15/2011 | US20110224300 USE OF POTASSIUM 2-(a- HYDROXYPENTYL) BENZOATE IN THE MANUFACTURE OF MEDICAMENTS FOR PREVENTING AND/OR TREATING SENILE DEMENTIA |
| 09/15/2011 | US20110224298 Diene compounds for use in human epidermal cell repair and pharmaceutical and cosmetic compositions containing them |
| 09/15/2011 | US20110224297 Methods of administering prostratin and structural analogs thereof |
| 09/15/2011 | US20110224295 Crystalline form of a (3s)-aminomethyl-5-methyl-hexanoic acid prodrug and methods of use |
| 09/15/2011 | US20110224294 Cinamic compounds and derivatives therefrom for the inhibition of histone deacetylase |
| 09/15/2011 | US20110224293 Use of dronedarone for the preparation of a medicament for use in the prevention of cardiovascular hospitalization or of mortality |
| 09/15/2011 | US20110224292 Method and apparatus for determining anticoagulant therapy factors |
| 09/15/2011 | US20110224291 Skin external composition for inhibiting epidermal hyperproliferation and alleviating inflammatory skin diseases containing orthodihydroxyisoflavone derivatives |
| 09/15/2011 | US20110224290 Combine use of pterostilbene and quercetin for the production of cancer treatment medicaments |
| 09/15/2011 | US20110224289 Compounds of the pterocarpanquinone family, method for preparing the same, pharmaceutical composition containing the new compounds of the pterocarpanquinone family, uses and therapeutic method |
| 09/15/2011 | US20110224288 Cancer Cell Targeting Using Nanoparticles |
| 09/15/2011 | US20110224287 Augmented cognitive training |
| 09/15/2011 | US20110224286 MICRO RNA (MiRNA) AND NEUROFIBROMATOSIS TYPE 1: A ROLE IN DIAGNOSIS AND THERAPY |
| 09/15/2011 | US20110224285 Oligomeric compounds for the modulation of hif-1a expression |
| 09/15/2011 | US20110224284 Putative tumor suppressor microrna-101 modulates the cancer epigenome by repressing the polycomb group protein ezh2 |
| 09/15/2011 | US20110224283 Antisense modulation of nuclear hormone receptors |
| 09/15/2011 | US20110224282 iRNA Agents Targeting VEGF |
| 09/15/2011 | US20110224281 Rna antagonists targeting hsp70-2 |
| 09/15/2011 | US20110224280 Pharmaceutical Composition Comprising Anti PCSK9 Oligomers |
| 09/15/2011 | US20110224279 Anticancer agent |
| 09/15/2011 | US20110224278 Methods and compositions for treating a subject for central nervous system (cns) injury |
| 09/15/2011 | US20110224277 Oligomeric Compounds And Compositions For Use In Modulation Of Small Non-Coding RNAs |